ARG1 and neoplasm: Using the arginase-1 inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) alone or in combination with the PD-1 inhibitor nivolumab, a significant reduction in arginase-1 activity and tumor mass was recorded [84].